The Evolving Endocrine Management of Metastatic Breast Cancer

Document Type

Presentation

Loading...

Media is loading
 

Publication Date

1-23-2014

Abstract

At the conclusion of this presentation the participant should be able to:

1. Recognize the clinical and molecular subtypes of breast cancer.

2. Recognize the standard endocrine therapies for Estrogen-resistant metastatic breast cancer.

3. Recognize and implement novel molecular therapies in Estrogen-resistant metastatic breast cancer.

Presentation: 32 minutes

This document is currently not available here.

Share

COinS